Trustees of Columbia University in the City of New York’s Vor Biopharma VOR Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,595	Closed	-$224K	–	8
2025 Q3	$224K	Sell	4,595 -1	-0%	-$40	0.03%	6
2025 Q2	$149K	Hold	4,596	–	–	0.02%	8
2025 Q1	$66K	Hold	4,596	–	–	0.01%	9
2024 Q4	$102K	Buy	+4,596	New	+$76.2K	0.02%	12
2023 Q4	$207K	Hold	4,596	–	–	0.44%	9
2023 Q3	$195K	Hold	4,596	–	–	0.36%	13
2023 Q2	$284K	Hold	4,596	–	–	0.42%	13
2023 Q1	$494K	Hold	4,596	–	–	0.88%	10
2022 Q4	$611K	Buy	+4,596	New	+$455K	1.26%	8
2021 Q3	$1.44M	Sell	4,596 -4,595	-50%	-$1.37M	2.2%	8
2021 Q2	$3.43M	Hold	9,191	–	–	5.06%	4
2021 Q1	$7.92M	Buy	+9,191	New	+$7.78M	9.6%	5

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Trustees of Columbia University in the City of New York's VOR Position: Q4 2025 in Review

Trustees of Columbia University in the City of New York sold out of Vor Biopharma (VOR) in Q4 2025, closing a stake of 4,595 shares — an estimated $224K sold.

Trustees of Columbia University in the City of New York first reported a position in VOR in Q1 2021 and held it in 12 quarters. The position peaked at $7.92M in Q1 2021. 55 funds tracked by Wall St. Rank hold VOR as of Q4 2025.

Trustees of Columbia University in the City of New York reported no remaining Vor Biopharma position as of Q4 2025 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 4,595 Vor Biopharma shares in Q4 2025, an estimated $224K.
Trustees of Columbia University in the City of New York first reported a position in Vor Biopharma in Q1 2021 and held it in 12 quarters.
Trustees of Columbia University in the City of New York's Vor Biopharma position peaked at $7.92M in Q1 2021.
55 funds tracked by Wall St. Rank held Vor Biopharma as of Q4 2025.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q4 2025, filed 13 Feb 2026.